Scientists are genetically engineering microbes to withstand industrial conditions for biofuel production. Researchers found that partially suppressing genes in cyanobacteria improved their growth ...

What tech companies peddle as artificial intelligence (AI) is only artificial. It is not intelligence. Only humans are endowed with the virtue of ...

Cocoa prices are soaring as climate change and supply chain disruptions hit global production. Discover how food tech ...

The Shenzhou-21 crew has been marooned on China's Tiangong space station after three of their colleagues were brought back to ...

While traditional induction therapy for newly diagnosed stage 2 myeloma often focuses on combinations of proteasome inhibitors, immunomodulatory drugs, and steroids, these newer immunotherapy classes ...

In a state famous for its endless horizons and agricultural prowess, Lauritzen Gardens stands as Omaha’s lush rebellion against the stereotype that Nebraska is just one giant cornfield with a football ...

Researchers at Stockholm University recovered intact RNA molecules – the chemical messengers that reveal which genes were active – from a 39,000-year-old male mammoth named Yuka. The breakthrough, ...

Tanshinones, bioactive compounds in Salvia miltiorrhiza (Chinese sage), hold significant therapeutic value, particularly in ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

Editing genes in sperm, eggs and embryos is currently banned in the United States. The current effort by Preventive, a Silicon Valley startup, involves a couple with a genetic abnormality who want to ...

Scientists have taught bacteria to make octopus camouflage pigment, ushering in a new era of bio-inspired materials.

Kevin Fitzgerald, Alnylam Pharmaceuticals’ chief scientific officer, reveals the hard times that led to RNAi success, and what it takes to pave new roads in biotech.